Notices and Activity Reports

Patented (Shinbiosis, Inc.)

We are pleased to announce that we have been granted a patent for the “bioinduction aid solvent and method of its use,” for which an application was filed by Symbiosis, Inc.

Patent Information

【Patent No.】
Patent No. 7231799

Title of the Invention:
“Bioinduction aid solvent and method of use thereof.”

【Date patented】
February 21, 2023

*Patent Information Platform
Please query with the patent number “7231799”.

For inquiries regarding this matter, please contact

Shinbiosis Corporation

For inquiries, please contact us from “Contact us” on the top page.

Articles about other Notices and Activity Reports

November 16, 2026

10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]

The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 06, 2026

Survey Summary from the 10th Annual Academic Conference

The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

October 28, 2024

〈Clinical Trial〉Completion Report

We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]